Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 9/20 | 0.39 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.36 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.33 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17876254 | 0.96 | PRKDC (0.37) | PRKDCALKPLA2G2APLA2G4APLA2G10 | |
| SCHEMBL17876261 | 0.96 | PRKDC (0.37) | PRKDCALKPLA2G2APLA2G4APLA2G10 | |
| SCHEMBL17876306 | 0.94 | MAPT (0.38) | PRKDCNPC1MAPTRAB9AALOX5 | |
| SCHEMBL17876305 | 0.91 | PRKDC (0.36) | PRKDCALKPLA2G2APLA2G4APLA2G10 | |
| SCHEMBL17876299 | 0.91 | PRKDC (0.42) | PRKDCNPC1MAPTRAB9AALOX5 | |
| SCHEMBL17876308 | 0.91 | ALDH1A1 (0.38) | PRKDCALKNPC1MAPTRAB9A | |
| SCHEMBL17876311 | 0.90 | ALK (0.36) | PRKDCALKMAPTCLK4 | |
| SCHEMBL17876253 | 0.90 | MAPT (0.35) | PRKDCNPC1MAPTRAB9AALOX5 | |
| SCHEMBL17876292 | 0.88 | ALOX5 (0.48) | PRKDCMAPTALOX5 | |
| SCHEMBL17876294 | 0.88 | ALOX5 (0.48) | PRKDCALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | PRKDC 4858/4885ALK 4572/4885PLA2G2A 4359/4885 |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | PRKDC 4858/4885ALK 4572/4885PLA2G2A 4359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.